Identification and characterization of macrophage inflammatory protein 2.

In response to endotoxin, macrophages secrete a protein with a molecular mass of approximately 6000 Da and with an affinity for heparin. This protein, which we term "macrophage inflammatory protein 2," is a potent chemotactic agent for human polymorphonuclear leukocytes. In addition, subcutaneous administration of the monokine causes a localized inflammatory reaction. Partial N-terminal sequence data reveal similarity to a family of proteins, the archetype of which is platelet factor 4. Although macrophage inflammatory protein 2 is a distinct member of the platelet factor 4 family, its sequence is most closely related to that of the gro/KC gene product, which is expressed in transformed or platelet-derived growth factor-treated cells.

[1]  B. Rollins,et al.  Comparison of fibroblast and T-cell activation genes. , 1988, Cellular immunology.

[2]  T. Schall,et al.  A human T cell-specific molecule is a member of a new gene family. , 1988, Journal of immunology.

[3]  B. Rollins,et al.  Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Cerami,et al.  Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties [published erratum appears in J Exp Med 1989 Dec 1;170(6):2189] , 1988, The Journal of experimental medicine.

[5]  B. Dewald,et al.  A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.

[6]  J. van Beeumen,et al.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity , 1988, The Journal of experimental medicine.

[7]  L. Moldawer,et al.  Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties , 1988, The Journal of experimental medicine.

[8]  M. Baggiolini,et al.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. , 1987, Biochemical and biophysical research communications.

[9]  E. Appella,et al.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Schröder,et al.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. , 1987, Journal of immunology.

[11]  G. Freeman,et al.  Cloning and characterization of a novel T cell activation gene. , 1987, Journal of immunology.

[12]  L. Bardwell,et al.  Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Mori,et al.  Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha. , 1987, Blood.

[14]  K. Matsushima,et al.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.

[15]  C. Weissmann,et al.  Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes. , 1987, Journal of immunology.

[16]  S. Sugano,et al.  Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein , 1987, Cell.

[17]  A. Mantovani,et al.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. , 1987, Journal of immunology.

[18]  R. Rosenberg,et al.  Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation , 1987, Molecular and cellular biology.

[19]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[20]  D. Walz,et al.  Isolation and amino acid sequence of bovine platelet factor 4. , 1986, Archives of biochemistry and biophysics.

[21]  J. Gamble,et al.  Stimulation of neutrophils by tumor necrosis factor. , 1986, Journal of immunology.

[22]  A. Henschen,et al.  Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. , 1986, Biochemistry.

[23]  T. Hyers,et al.  In Vitro Effects of Platelet Factor 4 on Normal Human Neutrophil Functions , 1986, Journal of leukocyte biology.

[24]  M. Fukuda,et al.  A cDNA clone used to study mRNA inducible in human tonsillar lymphocytes by a tumor promoter. , 1986, Journal of biochemistry.

[25]  Andrew D. Luster,et al.  γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.

[26]  D. Lipman,et al.  Rapid and sensitive protein similarity searches. , 1985, Science.

[27]  K. Austen,et al.  The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. , 1984, The Journal of clinical investigation.

[28]  Brent H. Cochran,et al.  Molecular cloning of gene sequences regulated by platelet-derived growth factor , 1983, Cell.

[29]  E. Kaiser,et al.  The carboxyl-terminal tridecapeptide of platelet factor 4 is a potent chemotactic agent for monocytes. , 1982, Biochemical and biophysical research communications.

[30]  R. Heinrikson,et al.  Platelet factor 4 is chemotactic for neutrophils and monocytes. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Rappaport,et al.  Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. , 1987, Blood.

[32]  R. Snyderman,et al.  Chemoattractant receptors on phagocytic cells. , 1984, Annual review of immunology.

[33]  F. Valone.  Regulation of human leukocyte function by lipoxygenase products of arachidonic acid. , 1984, Contemporary topics in immunobiology.

[34]  P. Cuatrecasas,et al.  Formyl peptide chemotactic receptors of leukocytes and macrophages. , 1980, Current topics in cellular regulation.

[35]  P. Henson,et al.  Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. , 1980, Immunopharmacology.